Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
grade A 149.5 1.67% 2.45
DXCM closed up 1.67 percent on Thursday, January 17, 2019, on 52 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical DXCM trend table...

Date Alert Name Type % Chg
Jan 17 New 52 Week Closing High Bullish 0.00%
Jan 17 Multiple of Ten Bearish Other 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 16 Wide Bands Range Expansion 1.67%
Jan 16 Overbought Stochastic Strength 1.67%
Jan 15 Stochastic Sell Signal Bearish 1.67%
Jan 15 Pocket Pivot Bullish Swing Setup 1.67%
Jan 15 Upper Bollinger Band Walk Strength 1.67%
Jan 15 Wide Bands Range Expansion 1.67%

Older signals for DXCM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Is DXCM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 152.14
52 Week Low 52.92
Average Volume 1,677,495
200-Day Moving Average 113.4855
50-Day Moving Average 128.1748
20-Day Moving Average 126.278
10-Day Moving Average 138.58
Average True Range 5.8887
ADX 24.67
+DI 37.6601
-DI 14.3345
Chandelier Exit (Long, 3 ATRs ) 133.3139
Chandelier Exit (Short, 3 ATRs ) 122.7161
Upper Bollinger Band 154.9486
Lower Bollinger Band 97.6074
Percent B (%b) 0.9
BandWidth 45.408701
MACD Line 6.624
MACD Signal Line 3.2321
MACD Histogram 3.3919
Fundamentals Value
Market Cap 12.95 Billion
Num Shares 86.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -196.71
Price-to-Sales 6.08
Price-to-Book 10.87
PEG Ratio -1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 156.03
Resistance 3 (R3) 155.79 153.39 154.94
Resistance 2 (R2) 153.39 151.72 153.50 154.57
Resistance 1 (R1) 151.44 150.70 152.42 151.68 154.21
Pivot Point 149.04 149.04 149.52 149.15 149.04
Support 1 (S1) 147.09 147.37 148.07 147.33 144.79
Support 2 (S2) 144.69 146.35 144.80 144.43
Support 3 (S3) 142.74 144.69 144.06
Support 4 (S4) 142.98